Researchers at The University of Texas MD Anderson Cancer Center have identified a specific protein, RASH3D19, that is ...

Skin is not just a passive covering, it is an active security system that constantly scans for damage and quietly repairs it ...

Artelo Biosciences, Inc. (Nasdaq: ARTL) (“Artelo” or the “Company”), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with ...

Researchers have solved the decades-old mystery behind how a common pregnancy drug lowers blood pressure. It turns out the ...

An aggressive breast cancer lacking common drug targets, triple-negative breast cancer may be countered by oridonin, a ...

Lung cancer remains the most frequently diagnosed malignancy and the leading cause of cancer tumour-related mortality ...

Hepatocellular carcinoma (HCC) is the sixth leading cause of cancer-related mortality worldwide.1 Despite therapeutic ...

In several disease conditions, including infections and cancers, innate immune activation and nutrient scarcity occur together.

After a finite number of divisions, cells simply give up. As each round of replication trims their telomeres-the protective ...

PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA levels in a dose-related manner. MIAMI, FLORIDA / ACCESS Newswire / November ...

After a finite number of divisions, cells simply give up. As each round of replication trims their telomeres—the protective ...

Combined androgen blockade shows significant survival benefits over single-agent ADT in high-risk prostate cancer, as ...